Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) saw a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 46,500 shares, a decrease of 24.0% from the February 13th total of 61,200 shares. Based on an average daily volume of 27,200 shares, the short-interest ratio is presently 1.7 days. Approximately 2.2% of the shares of the company are short sold.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.
Check Out Our Latest Report on Kewaunee Scientific
Insiders Place Their Bets
Hedge Funds Weigh In On Kewaunee Scientific
Institutional investors and hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC grew its stake in shares of Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after purchasing an additional 1,941 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after purchasing an additional 900 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in Kewaunee Scientific during the fourth quarter valued at approximately $338,000. Barclays PLC acquired a new position in Kewaunee Scientific in the third quarter worth approximately $121,000. Finally, IFP Advisors Inc bought a new position in shares of Kewaunee Scientific in the fourth quarter valued at $36,000. Institutional investors own 32.69% of the company’s stock.
Kewaunee Scientific Stock Performance
Shares of KEQU opened at $49.69 on Wednesday. The firm has a 50-day moving average price of $58.16 and a 200 day moving average price of $47.77. The firm has a market capitalization of $142.71 million, a PE ratio of 7.87 and a beta of 0.71. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. Kewaunee Scientific has a 52-week low of $30.82 and a 52-week high of $71.33.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last announced its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The firm had revenue of $67.17 million during the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Retail Sales Data Signals a Surge: The E-Commerce Stock Picks
- What Are Treasury Bonds?
- Qualcomm’s Low PE Ratio Makes It A Seriously Attractive Stock
- What is Insider Trading? What You Can Learn from Insider Trading
- Dollar General Stock Jumps—Will Its Turnaround Plan Work?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.